- Investing Ideas
- /
- U.S. Large Cap High Growth Potential
U.S. Large Cap High Growth Potential
Results
249
15 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
249 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$196.52 | 3.4% | 57.8% | US$62.1b | US$197.14 | PE91.8x | E38.4% | 1.9% | Diversified Financials | ||
ALNY | US$274.55 | -0.8% | 60.8% | US$35.0b | US$299.74 | PS16.9x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$58.52 | -2.3% | 115.4% | US$19.2b | US$62.47 | PE135.7x | E29.7% | n/a | Consumer Durables | ||
NVDA | US$116.66 | -1.5% | 68.3% | US$2.9t | US$173.78 | PE45.3x | E21.7% | 0.03% | Semiconductors | ||
MRVL | US$113.56 | 13.2% | 69.4% | US$97.7b | US$129.25 | PS18.3x | E55.6% | 0.2% | Semiconductors | ||
NU | US$13.14 | 6.7% | 41.7% | US$63.6b | US$15.06 | PB8.3x | E25.2% | n/a | Banks | ||
ITCI | US$127.19 | -0.02% | 84.3% | US$13.5b | US$128.64 | PS22x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$95.67 | -1.2% | 5.3% | US$18.1b | US$126.60 | PE9.8x | E20.8% | 6.8% | Diversified Financials | ||
SMCI | US$26.85 | -7.6% | -59.5% | US$16.7b | US$40.79 | PE13x | E24.3% | n/a | Tech | ||
PLTR | US$83.74 | 11.0% | 400.8% | US$187.9b | US$54.21 | PE400.3x | E28.7% | n/a | Software | ||
DASH | US$190.80 | 4.6% | 76.5% | US$78.4b | US$186.48 | PS7.8x | E43.9% | n/a | Consumer Services | ||
NTNX | US$68.77 | 9.2% | 19.9% | US$18.4b | US$81.89 | PS8.3x | E92.0% | n/a | Software | ||
VRT | US$112.60 | 9.7% | 82.9% | US$43.9b | US$143.31 | PE72.7x | E26.8% | 0.1% | Capital Goods | ||
EXE | US$102.87 | 1.4% | 36.5% | US$23.5b | US$118.24 | PE93.6x | E64.5% | 2.2% | Energy | ||
SN | US$109.00 | -2.3% | 128.8% | US$15.7b | US$122.87 | PE42.5x | E22.4% | n/a | Consumer Durables | ||
CRDO | US$71.81 | 29.2% | 237.0% | US$11.7b | US$79.54 | PS48.9x | E66.2% | n/a | Semiconductors | ||
RYAN New | US$67.45 | 3.2% | 58.4% | US$17.4b | US$73.98 | PE83x | E43.9% | 0.7% | Insurance | ||
XPEV | US$15.69 | 4.0% | 99.4% | US$14.4b | US$14.80 | PS2.9x | E56.7% | n/a | Automobiles | ||
SPOT | US$549.08 | 6.8% | 145.9% | US$110.9b | US$496.20 | PE153.8x | E26.6% | n/a | Media | ||
CVNA | US$251.63 | 3.9% | 474.5% | US$52.3b | US$253.41 | PE1902.2x | E37.2% | n/a | Retail | ||
ZS | US$200.00 | 4.6% | -13.8% | US$31.1b | US$226.04 | PS13.3x | E39.7% | n/a | Software | ||
SRPT | US$113.81 | -3.1% | -10.0% | US$10.9b | US$185.16 | PE89.2x | E29.8% | n/a | Pharmaceuticals & Biotech | ||
CTRA | US$28.04 | 0.8% | 15.9% | US$20.4b | US$34.33 | PE16.7x | E25.4% | 3.0% | Energy | ||
ARM | US$155.65 | 6.6% | 112.4% | US$167.7b | US$148.04 | PE255.2x | E31.3% | n/a | Semiconductors |